Fertility Clinic Chain Indira IVF Withdraws Confidential IPO Papers

Indira IVF Hospital has withdrawn its draft IPO papers after using the confidential pre-filing route, which was acknowledged by Sebi. While this route offers flexibility, it does not guarantee an IPO launch. Other companies like PhysicsWallah and Swiggy have used this route successfully, though some, like Tata Play, opted not to proceed.

Fertility clinic chain Indira IVF Hospital has retracted its draft Initial Public Offering (IPO) documents, filed through the confidential route. The disclosure emerged in a recent update from the Securities and Exchange Board of India (Sebi).

This confidential filing method allows companies to keep details under wraps as part of the Draft Red Herring Prospectus (DRHP), without necessarily committing to an IPO. Despite pre-filing DRHP on February 13, Indira IVF pulled back its draft offer on March 19, 2025, without providing explanations.

The confidential filing avenue has been taken by companies like PhysicsWallah, Swiggy, and Vishal Mega Mart, with varying outcomes. This method provides up to 18 months post-Sebi's final comments for IPO launching—more flexible compared to traditional routes. Meanwhile, Agriwarehousing & Collateral Management Ltd's draft IPO, involving up to Rs 450 crore, was returned by Sebi on March 19.

(With inputs from agencies.)